Abiopharma

Dividend in the amount of 389.15 agorot per share, record date: 30.3.26, payment 20.4.26

Moleculin Hits 45 Subject Enrollment Milestone, Triggering Final Countdown to Mid-2026 MIRACLE Trial Data Readout

Full exchange tender offer for the company’s shares – the condition for carrying out a forced sale was not met, no shares will be purchased

Management and officers – staffing as of 23.3.26

Net Asset Value(s)

Venture Global e Vitol annunciano un nuovo accordo di acquisto di GNL

LTM、AppIQ・AgentIQ・FusionIQの投入によりBlueVerse™ Techを拡張、AI主導型エンジニアリングを加速

The company’s liability position as of 31.12.25, by maturity dates

MKT Capital Applauds Aurinia Pharmaceuticals’ Management Transition

Venture Global und Vitol geben neuen LNG-Kaufvertrag bekannt